Abstract: Methods are disclosed for treating ovarian tumors and ovarian and pancreatic cancers using computed and normalized relative ratios of plasma levels of phospholipids, particularly lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine and sphingomyelin.

Abstract: Techniques are disclosed relating to providing fast access to restored data in a cloud storage environment. A computing system stores multiple sets of incremental backup data that reflect changes in data being backed up between backup intervals and metadata that indicates which set of incremental backup data stores a given object. The computing system generates an endpoint for a requesting computing system, where the endpoint supports requests for restored backup data and data responses. In response to a request from the requesting computing system via the endpoint, the computing system queries the metadata based on the request and stores metadata retrieved from the query in a key/value store using object identification information as key data and the retrieved metadata as value data. The computing system provides requested data according to a lazy loading technique, including providing requested data via the endpoint based on the metadata in the key/value store.

Abstract: Techniques are disclosed relating to providing fast access to restored data in a cloud storage environment. A computing system stores multiple sets of incremental backup data that reflect changes in data being backed up between backup intervals and metadata that indicates which set of incremental backup data stores a given object. The computing system generates an endpoint for a requesting computing system, where the endpoint supports requests for restored backup data and data responses. In response to a request from the requesting computing system via the endpoint, the computing system queries the metadata based on the request and stores metadata retrieved from the query in a key/value store using object identification information as key data and the retrieved metadata as value data. The computing system provides requested data according to a lazy loading technique, including providing requested data via the endpoint based on the metadata in the key/value store.

Abstract: Techniques are disclosed relating to providing fast access to restored data in a cloud storage environment. A computing system stores multiple sets of incremental backup data that reflect changes in data being backed up between backup intervals and metadata that indicates which set of incremental backup data stores a given object. The computing system generates an endpoint for a requesting computing system, where the endpoint supports requests for restored backup data and data responses. In response to a request from the requesting computing system via the endpoint, the computing system queries the metadata based on the request and stores metadata retrieved from the query in a key/value store using object identification information as key data and the retrieved metadata as value data. The computing system provides requested data according to a lazy loading technique, including providing requested data via the endpoint based on the metadata in the key/value store.

Abstract: The present invention provides for methods for reducing brain injury in or increasing survival of a subject that is suffering or has suffered cardiac arrest. These methods comprise administering an effective amount of a pharmaceutical composition comprising a lysophosphatidylcholine selected from the group consisting of lysophosphatidylcholine (18:1), lysophosphatidylcholine (18:2), lysophosphatidylcholine (22:6), and/or a combination thereof, optionally lysophosphatidylcholine (18:0), and a pharmaceutical carrier to the subject. The present invention further provides for the pharmaceutical compositions employed in these methods.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of diabetes, obesity, dyslipidemia, or metabolic syndrome by administering in combination with a GLP-1 (glucagon-like peptide-1) receptor agonist, comprising a GDF15 (growth differentiation factor-15) variant, a long-acting GDF15 fusion protein, or a long-acting GDF15 fusion protein dimer as an active ingredient.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH), comprising a GDF15 (growth differentiation factor-15) variant, a long-acting GDF15 fusion protein, or a long-acting GDF15 fusion protein dimer as an active ingredient.

Abstract: Methods are disclosed for treating ovarian tumors and ovarian and pancreatic cancers using computed and normalized relative ratios of plasma levels of phospholipids, particularly lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine and sphingomyelin.

Abstract: Methods are disclosed for treating ovarian tumors and ovarian and pancreatic cancers using computed and normalized relative ratios of plasma levels of phospholipids, particularly lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine and sphingomyelin.

Abstract: A fusion protein including a GDF15 variant having increased physiological activity and in vivo stability, and a pharmaceutical composition containing the same are disclosed. The GDF15 variant or long-acting GDF15 fusion protein is superior to conventional GDF15 variants in terms of in vitro efficacy, binding affinity for GDF15 receptors, and body weight loss effect. Therefore, a pharmaceutical composition containing, as an active ingredient, the GDF15 variant, the long-acting GDF15 fusion protein, or a dimer of the fusion protein, causes appetite suppression, and thus can be effectively used as a therapeutic agent for metabolic diseases or obesity. Furthermore, the pharmaceutical composition can be used in combination therapy or the like with chemical drugs and other therapeutic agents for metabolic diseases, and can be effectively used in combination therapy with conventional therapeutic agents for metabolic diseases or obesity.

Abstract: Methods are disclosed for treating ovarian tumors and ovarian and pancreatic cancers using computed and normalized relative ratios of plasma levels of phospholipids, particularly lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine and sphingomyelin.

Abstract: Disclosed herein are a method of generating a correlation function with no side-peak and a system for tracking a BOC signal in order to synchronize the BOC signal. The method of generating a correlation function includes step S1 of generating sub-correlation functions {Sl(?)}l=0N?1, step S2 of generating a first final correlation function R0(?) by combining some of the sub-correlation functions, and step S3 of generating a second final correlation function Rproposed(?) by combining R0(?) with each of the remaining sub-correlation functions that have not been used for the combination at step S2. The BOC signal is one or more of BOCsin(kn,n) and BOCcos(kn,n) signals.

Abstract: A mobile terminal and controlling method thereof are disclosed, by which a sharp and clear photo can be composed using a plurality of photos taken by burst shooting. The present invention includes a camera, a sensing unit configured to detect a surrounding brightness, a user input unit configured to receive a photographing command, and a controller, if the photographing command is received, taking a first number of photos by burst shooting, the controller outputting a shaking eliminated photo based on a second number of photo(s) selected from the first number of the taken photos, wherein the second number is determined based on the detected surrounding brightness.

Abstract: A system and method includes a laser to create a control laser signal and a laser to create a probe laser signal. A resonator creates an acoustic signal adjacent the control laser signal and the probe laser signal. A resulting coherent interaction between the control laser signal and the probe laser signal creates a Brillouin scattering induced transparency in one direction and maintains opacity in an opposite direction.

Abstract: A system and method includes a laser to create a control laser signal and a laser to create a probe laser signal. A resonator creates an acoustic signal adjacent the control laser signal and the probe laser signal. A resulting coherent interaction between the control laser signal and the probe laser signal creates a Brillouin scattering induced transparency in one direction and maintains opacity in an opposite direction.

Abstract: A mobile terminal and controlling method thereof are disclosed, by which a sharp and clear photo can be composed using a plurality of photos taken by burst shooting. The present invention includes a camera, a sensing unit configured to detect a surrounding brightness, a user input unit configured to receive a photographing command, and a controller, if the photographing command is received, taking a first number of photos by burst shooting, the controller outputting a shaking eliminated photo based on a second number of photo(s) selected from the first number of the taken photos, wherein the second number is determined based on the detected surrounding brightness.

Abstract: A method and an apparatus of estimating a frequency offset in a wireless communication system are provided. An orthogonal frequency division multiplexing (OFDM) receiver performs envelope equalized processing (EEP) with respect to a reception signal and calculates a partial periodogram with a plurality of test values based on the reception signal which goes through the EEP. The OFDM receiver estimates a first frequency offset, a second frequency offset, and a third frequency offset based on two partial periodograms adjacent to each other among the partial periodograms for the plurality of test values.

Abstract: Disclosed herein are a method of generating a correlation function with no side-peak and a system for tracking a BOC signal in order to synchronize the BOC signal. The method of generating a correlation function includes step S1 of generating sub-correlation functions {Sl(?)}l=0N?1, step S2 of generating a first final correlation function R0(?) by combining some of the sub-correlation functions, and step S3 of generating a second final correlation function Rproposed(?) by combining R0(?) with each of the remaining sub-correlation functions that have not been used for the combination at step S2. The BOC signal is one or more of BOCsin(kn,n) and BOCcos(kn,n) signals.

Abstract: Provided is an apparatus for estimating a frequency offset by one training symbol including two symbols having the same structure and value in an OFDM system. The apparatus includes a first likelihood function calculator for modeling non-Gaussian impulsive noise included in the training symbol to a Cauchy probability density function in which a characteristic exponent of a BIS?S probability density function is 1, and calculating a likelihood function of a Cauchy distribution using the Cauchy probability density function, and a first frequency offset estimator for estimating an effective frequency offset value in which the likelihood function of the Cauchy distribution of the first likelihood function calculator becomes highest as a frequency offset estimation value. Thereby, it is possible to improve the performance of frequency offset estimation in non-Gaussian impulsive noise environments.

Abstract: A method and an apparatus of estimating a frequency offset in a wireless communication system are provided. An orthogonal frequency division multiplexing (OFDM) receiver performs envelope equalized processing (EEP) with respect to a reception signal and calculates a partial periodogram with a plurality of test values based on the reception signal which goes through the EEP. The OFDM receiver estimates a first frequency offset, a second frequency offset, and a third frequency offset based on two partial periodograms adjacent to each other among the partial periodograms for the plurality of test values.